Decentralized Clinical Trials Survey Report

Discover how the industry is pivoting to tackle clinical trials during the pandemic and beyond.

Questions posed in our survey generated insights on the impact of the COVID-19 pandemic on clinical trials globally – namely concerns over delays, interruptions and continuity, patient enrollment and retention, site operations and capacity, supply chain interruptions, patient safety and access, and regulatory changes.

PPD 2020 Decentralized Clinical Trials Survey Report Image